Exact Mass: 431.18384540000005
Exact Mass Matches: 431.18384540000005
Found 127 metabolites which its exact mass value is equals to given mass value 431.18384540000005
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Glenvastatin
C27H26FNO3 (431.18966180000007)
D057847 - Lipid Regulating Agents > D000960 - Hypolipidemic Agents > D000924 - Anticholesteremic Agents D004791 - Enzyme Inhibitors > D019161 - Hydroxymethylglutaryl-CoA Reductase Inhibitors C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent C471 - Enzyme Inhibitor > C1655 - HMG-CoA Reductase Inhibitor D009676 - Noxae > D000963 - Antimetabolites
DTXSID10996162
C23H36Cl3N (431.19131860000005)
Lafutidine
C22H29N3O4S (431.1878674000001)
Lafutidine is a histamine H2-receptor antagonist that inhibits histamine-stimulated gastric acid secretion. Due to the resulting reduction in gastric volume and acidity, lafutidine can be used to treat ulcers and reflux. A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
Lafutidine
C22H29N3O4S (431.1878674000001)
A - Alimentary tract and metabolism > A02 - Drugs for acid related disorders > A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) > A02BA - H2-receptor antagonists C78276 - Agent Affecting Digestive System or Metabolism > C29701 - Anti-ulcer Agent > C29702 - Histamine-2 Receptor Antagonist D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists D005765 - Gastrointestinal Agents > D000897 - Anti-Ulcer Agents Lafutidine (FRG-8813) is a histamine H2-receptor antagonist (H2RA), with proven gastric mucosal protective effects. Lafutidine can be used for the research of gastroesophageal reflux disease[1].
Ala Met Asn Pro
C17H29N5O6S (431.18384540000005)
Ala Met Pro Asn
C17H29N5O6S (431.18384540000005)
Ala Asn Met Pro
C17H29N5O6S (431.18384540000005)
Ala Asn Asn Asn
Ala Asn Pro Met
C17H29N5O6S (431.18384540000005)
Ala Pro Met Asn
C17H29N5O6S (431.18384540000005)
Ala Pro Asn Met
C17H29N5O6S (431.18384540000005)
Cys Asn Pro Val
C17H29N5O6S (431.18384540000005)
Cys Asn Val Pro
C17H29N5O6S (431.18384540000005)
Cys Pro Asn Val
C17H29N5O6S (431.18384540000005)
Cys Pro Val Asn
C17H29N5O6S (431.18384540000005)
Cys Val Asn Pro
C17H29N5O6S (431.18384540000005)
Cys Val Pro Asn
C17H29N5O6S (431.18384540000005)
Gly Met Pro Gln
C17H29N5O6S (431.18384540000005)
Gly Met Gln Pro
C17H29N5O6S (431.18384540000005)
Gly Asn Asn Gln
Gly Asn Gln Asn
Gly Pro Met Gln
C17H29N5O6S (431.18384540000005)
Gly Pro Gln Met
C17H29N5O6S (431.18384540000005)
Gly Gln Met Pro
C17H29N5O6S (431.18384540000005)
Gly Gln Asn Asn
Gly Gln Pro Met
C17H29N5O6S (431.18384540000005)
Met Ala Asn Pro
C17H29N5O6S (431.18384540000005)
Met Ala Pro Asn
C17H29N5O6S (431.18384540000005)
Met Gly Pro Gln
C17H29N5O6S (431.18384540000005)
Met Gly Gln Pro
C17H29N5O6S (431.18384540000005)
Met Asn Ala Pro
C17H29N5O6S (431.18384540000005)
Met Asn Pro Ala
C17H29N5O6S (431.18384540000005)
Met Pro Ala Asn
C17H29N5O6S (431.18384540000005)
Met Pro Gly Gln
C17H29N5O6S (431.18384540000005)
Met Pro Asn Ala
C17H29N5O6S (431.18384540000005)
Met Pro Gln Gly
C17H29N5O6S (431.18384540000005)
Met Gln Gly Pro
C17H29N5O6S (431.18384540000005)
Met Gln Pro Gly
C17H29N5O6S (431.18384540000005)
Asn Ala Met Pro
C17H29N5O6S (431.18384540000005)
Asn Ala Asn Asn
Asn Ala Pro Met
C17H29N5O6S (431.18384540000005)
Asn Cys Pro Val
C17H29N5O6S (431.18384540000005)
Asn Cys Val Pro
C17H29N5O6S (431.18384540000005)
Asn Gly Asn Gln
Asn Gly Gln Asn
Asn Met Ala Pro
C17H29N5O6S (431.18384540000005)
Asn Met Pro Ala
C17H29N5O6S (431.18384540000005)
Asn Asn Ala Asn
Asn Asn Gly Gln
Asn Asn Asn Ala
Asn Asn Gln Gly
Asn Pro Ala Met
C17H29N5O6S (431.18384540000005)
Asn Pro Cys Val
C17H29N5O6S (431.18384540000005)
Asn Pro Met Ala
C17H29N5O6S (431.18384540000005)
Asn Pro Val Cys
C17H29N5O6S (431.18384540000005)
Asn Gln Gly Asn
Asn Gln Asn Gly
Asn Val Cys Pro
C17H29N5O6S (431.18384540000005)
Asn Val Pro Cys
C17H29N5O6S (431.18384540000005)
Pro Ala Met Asn
C17H29N5O6S (431.18384540000005)
Pro Ala Asn Met
C17H29N5O6S (431.18384540000005)
Pro Cys Asn Val
C17H29N5O6S (431.18384540000005)
Pro Cys Val Asn
C17H29N5O6S (431.18384540000005)
Pro Gly Met Gln
C17H29N5O6S (431.18384540000005)
Pro Gly Gln Met
C17H29N5O6S (431.18384540000005)
Pro Met Ala Asn
C17H29N5O6S (431.18384540000005)
Pro Met Gly Gln
C17H29N5O6S (431.18384540000005)
Pro Met Asn Ala
C17H29N5O6S (431.18384540000005)
Pro Met Gln Gly
C17H29N5O6S (431.18384540000005)
Pro Asn Ala Met
C17H29N5O6S (431.18384540000005)
Pro Asn Cys Val
C17H29N5O6S (431.18384540000005)
Pro Asn Met Ala
C17H29N5O6S (431.18384540000005)
Pro Asn Val Cys
C17H29N5O6S (431.18384540000005)
Pro Gln Gly Met
C17H29N5O6S (431.18384540000005)
Pro Gln Met Gly
C17H29N5O6S (431.18384540000005)
Pro Val Cys Asn
C17H29N5O6S (431.18384540000005)
Pro Val Asn Cys
C17H29N5O6S (431.18384540000005)
Gln Gly Met Pro
C17H29N5O6S (431.18384540000005)
Gln Gly Asn Asn
Gln Gly Pro Met
C17H29N5O6S (431.18384540000005)
Gln Met Gly Pro
C17H29N5O6S (431.18384540000005)
Gln Met Pro Gly
C17H29N5O6S (431.18384540000005)
Gln Asn Gly Asn
Gln Asn Asn Gly
Gln Pro Gly Met
C17H29N5O6S (431.18384540000005)
Gln Pro Met Gly
C17H29N5O6S (431.18384540000005)
Val Cys Asn Pro
C17H29N5O6S (431.18384540000005)
Val Cys Pro Asn
C17H29N5O6S (431.18384540000005)
Val Asn Cys Pro
C17H29N5O6S (431.18384540000005)
Val Asn Pro Cys
C17H29N5O6S (431.18384540000005)
Val Pro Cys Asn
C17H29N5O6S (431.18384540000005)
Val Pro Asn Cys
C17H29N5O6S (431.18384540000005)
L-Octahydroindole-2-carboxylic acid benzyl ester 4-methylbenzenesulfonate
C23H29NO5S (431.17663440000007)
Ethaverine hydrochloride
C24H30ClNO4 (431.18632500000007)
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C333 - Calcium Channel Blocker D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D002492 - Central Nervous System Depressants > D009294 - Narcotics > D053610 - Opiate Alkaloids C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor C93038 - Cation Channel Blocker
2-Methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one
1-Methyl-6-[(4-methyl-1-piperidinyl)sulfonyl]-3-[oxo(1-piperidinyl)methyl]-4-quinolinone
C22H29N3O4S (431.1878674000001)
1-methyl-N-(2-methylcyclohexyl)-4-oxo-6-(1-pyrrolidinylsulfonyl)-3-quinolinecarboxamide
C22H29N3O4S (431.1878674000001)
N-[4-(diethylsulfamoyl)phenyl]-4-(4-morpholinylmethyl)benzamide
C22H29N3O4S (431.1878674000001)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-6-oxo-7-phenyl-1-(2-pyridinylmethyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxylic acid methyl ester
3beta-Chloro-N,N-bis(2-chloroethyl)-androst-5-en-17beta-amine
C23H36Cl3N (431.19131860000005)
(2z,6e)-7-[(5r,5ar,6s,8as)-3-{[hydroxy(methoxy)methylidene]amino}-6-methyl-4-oxo-5h,5ah,6h,7h,8h,8ah,9h-cyclopenta[g]thiochromen-5-yl]-3-methylhepta-2,6-dienoic acid
C23H29NO5S (431.17663440000007)
(2s,10s,12r)-13-hydroxy-10-(2-methylbut-3-en-2-yl)-21-oxo-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-3-yl acetate
13-hydroxy-10-(2-methylbut-3-en-2-yl)-21-oxo-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-3-yl acetate
(2s,10r,12s)-3-acetyl-12,13-dihydroxy-10-(2-methylbut-3-en-2-yl)-1,3,14-triazapentacyclo[10.9.0.0²,¹⁰.0⁴,⁹.0¹⁵,²⁰]henicosa-4,6,8,13,15,17,19-heptaen-21-one
7-(3-{[hydroxy(methoxy)methylidene]amino}-6-methyl-4-oxo-5h,5ah,6h,7h,8h,8ah,9h-cyclopenta[g]thiochromen-5-yl)-3-methylhepta-2,6-dienoic acid
C23H29NO5S (431.17663440000007)